BioPharma Credit PLC (LON:BPCR)

BioPharma Credit Financials Overview

Financials in millions USD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	157.78	157.78	150.03	135.73	218.14	103.86
Revenue Growth	2.00%	5.17%	10.53%	-37.78%	110.03%	-5.59%
Gross Profit Gross Profit Growth	132.06	132.06	124.46	110.49	184.25	87.97
Operating Income Operating Income Growth	129.89	129.89	122.18	108.45	182.31	84.96
Net Income Net Income Growth	129.89	129.89	122.18	108.45	182.31	84.96
Earnings Per Share EPS Growth	0.11	0.11	0.10	0.08	0.13	0.06
EPS Growth	7.95%	14.11%	20.65%	-38.02%	116.18%	-4.78%

Cash & Debt

Selected indicators aren't available for this stock.

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	91.1	91.1	111.91	123.18	184.28	96.44
Free Cash Flow Free Cash Flow Growth	91.1	91.1	111.91	123.18	184.28	96.44
Free Cash Flow Growth	-7.07%	-18.60%	-9.15%	-33.15%	91.09%	66.06%

Data Source: Fiscal.ai Last updated: Feb 14, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 5, 2026

Data Sources Report a data error